Cargando…
Trimethylamine N‐Oxide and Mortality Risk in Patients With Peripheral Artery Disease
BACKGROUND: Production of the proatherogenic metabolite, trimethylamine N‐oxide (TMAO), from dietary nutrients by intestinal microbiota enhances atherosclerosis development in animal models and is associated with atherosclerotic coronary artery disease in humans. The utility of studying plasma level...
Autores principales: | Senthong, Vichai, Wang, Zeneng, Fan, Yiying, Wu, Yuping, Hazen, Stanley L., Tang, W. H. Wilson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121520/ https://www.ncbi.nlm.nih.gov/pubmed/27792653 http://dx.doi.org/10.1161/JAHA.116.004237 |
Ejemplares similares
-
Intestinal Microbiota‐Generated Metabolite Trimethylamine‐N‐Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort
por: Senthong, Vichai, et al.
Publicado: (2016) -
Loop Diuretics Inhibit Renal Excretion of Trimethylamine N-Oxide
por: Li, Daniel Y., et al.
Publicado: (2021) -
Effects of Lifestyle Intervention on Plasma Trimethylamine N-Oxide in Obese Adults
por: Erickson, Melissa L., et al.
Publicado: (2019) -
Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand
por: Senthong, Vichai, et al.
Publicado: (2021) -
Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease
por: Roncal, Carmen, et al.
Publicado: (2019)